Spots Global Cancer Trial Database for lmwh
Every month we try and update this database with for lmwh cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE | NCT05171075 | Venous Thromboe... Deep Venous Thr... Pulmonary Embol... | Abelacimab Dalteparin | 18 Years - | Anthos Therapeutics, Inc. | |
| Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH | NCT02552381 | Malignant Tumor | Fibrin Structur... | 18 Years - | Diagnostica Stago R&D | |
| Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma. | NCT02715492 | HCC | LMWH TACE | 40 Years - 60 Years | Tanta University | |
| The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma | NCT00827554 | Hepatocellular ... | LMWH TACE | 18 Years - 75 Years | Eastern Hepatobiliary Surgery Hospital | |
| A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE | NCT05171049 | Venous Thromboe... Deep Venous Thr... Pulmonary Embol... | Abelacimab Apixaban | 18 Years - | Anthos Therapeutics, Inc. | |
| The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma | NCT00827554 | Hepatocellular ... | LMWH TACE | 18 Years - 75 Years | Eastern Hepatobiliary Surgery Hospital | |
| Thromboprophylaxis After Surgery for Gynecologic Malignancy in China | NCT02935530 | Gynecologic Neo... Venous Thromboe... Low Molecular W... Argatroban | s-LMWH LMWH Argatroban | 16 Years - 70 Years | Huazhong University of Science and Technology | |
| Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH | NCT02552381 | Malignant Tumor | Fibrin Structur... | 18 Years - | Diagnostica Stago R&D | |
| Anticoagulation in Patients With Venous Thromboembolism and Cancer | NCT04618913 | Neoplasms Embolism | Apixaban Rivaroxaban Edoxaban Dabigatran VKA LMWH | 18 Years - | Pfizer | |
| Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH | NCT02552381 | Malignant Tumor | Fibrin Structur... | 18 Years - | Diagnostica Stago R&D | |
| Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma. | NCT02715492 | HCC | LMWH TACE | 40 Years - 60 Years | Tanta University | |
| Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to Apixaban | NCT04895553 | Glioma, Maligna... | Observation of ... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK) | NCT05112666 | Treatment of Ve... | Rivaroxaban (Xa... other DOACs LMWH | 18 Years - | Bayer | |
| A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK) | NCT05112666 | Treatment of Ve... | Rivaroxaban (Xa... other DOACs LMWH | 18 Years - | Bayer | |
| A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE | NCT05171049 | Venous Thromboe... Deep Venous Thr... Pulmonary Embol... | Abelacimab Apixaban | 18 Years - | Anthos Therapeutics, Inc. | |
| TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer | NCT05625932 | Colorectal Canc... Thromboembolism | Tinzaparin | 18 Years - | Galician Research Group on Digestive Tumors | |
| A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE | NCT05171075 | Venous Thromboe... Deep Venous Thr... Pulmonary Embol... | Abelacimab Dalteparin | 18 Years - | Anthos Therapeutics, Inc. | |
| Anticoagulation in Patients With Venous Thromboembolism and Cancer | NCT04618913 | Neoplasms Embolism | Apixaban Rivaroxaban Edoxaban Dabigatran VKA LMWH | 18 Years - | Pfizer |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
